Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

NCT05657743 is registered in ClinicalTrials.gov with Alpha Tau Medical LTD. as lead sponsor.

NCT NCT05657743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05657743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
Lead sponsor
Alpha Tau Medical LTD.
Phase
Not applicable
Overall status
Recruiting
Start date
August 16, 2023
Completion date
November 30, 2027
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic cancer, pancreatic adenocarcinoma, pancreatic cancer, unresectable pancreatic cancer